Recombinant and ovarian hyperstimulation syndrome Patient Reports February 13, 2012

Recombinant Side Effects Report #4644692-0
Recombinant side effect was reported by a Consumer or non-health professional from on Apr 13, 2005. Female patient, 33 years of age, was diagnosed with in vitro fertilisation and was treated with Recombinant. After drug was administered, patient experienced the following side effects: myocardial infarction, ovarian hyperstimulation syndrome. Recombinant dosage: unknown. Patient was hospitalized. Patient died.